Challenges in Colorectal Cancer: Second Edition

John H. Scholefield, Axel F Grothey, Herand Abcarian, Tim Maughan

Research output: Book/ReportBook

Abstract

The latest guidance on challenging and controversial aspects of colorectal cancer. Colorectal cancer is one of the most common forms of cancer in the US and Europe. Thousands of people are diagnosed with the disease every year and nearly half of these die as a result. As colorectal cancer is curable when detected early, a significant proportion of these deaths could be prevented by earlier diagnosis. Much has changed since the publication of the first edition of this book in 2001: introduction of screening programs, improved diagnosis and surgery for rectal cancer, and advances in adjuvant and palliative medical therapy to name but a few. Challenges in Colorectal Cancer provides the most up-to-date information on the new and emerging treatments. The second edition looks at the total patient management of this condition and is aimed at the entire medical team caring for those with colorectal cancer. It also contains the latest guidelines on epidemiology and prevention of colorectal cancer, and the application of molecular genetics. The expanded international editor team present advice on surgical management, including new laparoscopic and endoscopic techniques and the role of the pathologist. They also review hot topics in colorectal cancer treatment, including the role of radiotherapy, options for chemotherapy and new developments in vaccines and immunotherapy.

Original languageEnglish (US)
PublisherBlackwell Publishing Ltd
Number of pages282
ISBN (Print)1405127066, 9781405127066
DOIs
StatePublished - Jan 14 2008

Fingerprint

Colorectal Neoplasms
Rectal Neoplasms
Palliative Care
Immunotherapy
Publications
Molecular Biology
Early Diagnosis
Epidemiology
Radiotherapy
Vaccines
Guidelines
Drug Therapy
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Scholefield, J. H., Grothey, A. F., Abcarian, H., & Maughan, T. (2008). Challenges in Colorectal Cancer: Second Edition. Blackwell Publishing Ltd. https://doi.org/10.1002/9780470753231

Challenges in Colorectal Cancer : Second Edition. / Scholefield, John H.; Grothey, Axel F; Abcarian, Herand; Maughan, Tim.

Blackwell Publishing Ltd, 2008. 282 p.

Research output: Book/ReportBook

Scholefield, JH, Grothey, AF, Abcarian, H & Maughan, T 2008, Challenges in Colorectal Cancer: Second Edition. Blackwell Publishing Ltd. https://doi.org/10.1002/9780470753231
Scholefield JH, Grothey AF, Abcarian H, Maughan T. Challenges in Colorectal Cancer: Second Edition. Blackwell Publishing Ltd, 2008. 282 p. https://doi.org/10.1002/9780470753231
Scholefield, John H. ; Grothey, Axel F ; Abcarian, Herand ; Maughan, Tim. / Challenges in Colorectal Cancer : Second Edition. Blackwell Publishing Ltd, 2008. 282 p.
@book{870060e3d6484336a8de552f3f248447,
title = "Challenges in Colorectal Cancer: Second Edition",
abstract = "The latest guidance on challenging and controversial aspects of colorectal cancer. Colorectal cancer is one of the most common forms of cancer in the US and Europe. Thousands of people are diagnosed with the disease every year and nearly half of these die as a result. As colorectal cancer is curable when detected early, a significant proportion of these deaths could be prevented by earlier diagnosis. Much has changed since the publication of the first edition of this book in 2001: introduction of screening programs, improved diagnosis and surgery for rectal cancer, and advances in adjuvant and palliative medical therapy to name but a few. Challenges in Colorectal Cancer provides the most up-to-date information on the new and emerging treatments. The second edition looks at the total patient management of this condition and is aimed at the entire medical team caring for those with colorectal cancer. It also contains the latest guidelines on epidemiology and prevention of colorectal cancer, and the application of molecular genetics. The expanded international editor team present advice on surgical management, including new laparoscopic and endoscopic techniques and the role of the pathologist. They also review hot topics in colorectal cancer treatment, including the role of radiotherapy, options for chemotherapy and new developments in vaccines and immunotherapy.",
author = "Scholefield, {John H.} and Grothey, {Axel F} and Herand Abcarian and Tim Maughan",
year = "2008",
month = "1",
day = "14",
doi = "10.1002/9780470753231",
language = "English (US)",
isbn = "1405127066",
publisher = "Blackwell Publishing Ltd",

}

TY - BOOK

T1 - Challenges in Colorectal Cancer

T2 - Second Edition

AU - Scholefield, John H.

AU - Grothey, Axel F

AU - Abcarian, Herand

AU - Maughan, Tim

PY - 2008/1/14

Y1 - 2008/1/14

N2 - The latest guidance on challenging and controversial aspects of colorectal cancer. Colorectal cancer is one of the most common forms of cancer in the US and Europe. Thousands of people are diagnosed with the disease every year and nearly half of these die as a result. As colorectal cancer is curable when detected early, a significant proportion of these deaths could be prevented by earlier diagnosis. Much has changed since the publication of the first edition of this book in 2001: introduction of screening programs, improved diagnosis and surgery for rectal cancer, and advances in adjuvant and palliative medical therapy to name but a few. Challenges in Colorectal Cancer provides the most up-to-date information on the new and emerging treatments. The second edition looks at the total patient management of this condition and is aimed at the entire medical team caring for those with colorectal cancer. It also contains the latest guidelines on epidemiology and prevention of colorectal cancer, and the application of molecular genetics. The expanded international editor team present advice on surgical management, including new laparoscopic and endoscopic techniques and the role of the pathologist. They also review hot topics in colorectal cancer treatment, including the role of radiotherapy, options for chemotherapy and new developments in vaccines and immunotherapy.

AB - The latest guidance on challenging and controversial aspects of colorectal cancer. Colorectal cancer is one of the most common forms of cancer in the US and Europe. Thousands of people are diagnosed with the disease every year and nearly half of these die as a result. As colorectal cancer is curable when detected early, a significant proportion of these deaths could be prevented by earlier diagnosis. Much has changed since the publication of the first edition of this book in 2001: introduction of screening programs, improved diagnosis and surgery for rectal cancer, and advances in adjuvant and palliative medical therapy to name but a few. Challenges in Colorectal Cancer provides the most up-to-date information on the new and emerging treatments. The second edition looks at the total patient management of this condition and is aimed at the entire medical team caring for those with colorectal cancer. It also contains the latest guidelines on epidemiology and prevention of colorectal cancer, and the application of molecular genetics. The expanded international editor team present advice on surgical management, including new laparoscopic and endoscopic techniques and the role of the pathologist. They also review hot topics in colorectal cancer treatment, including the role of radiotherapy, options for chemotherapy and new developments in vaccines and immunotherapy.

UR - http://www.scopus.com/inward/record.url?scp=84889293464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889293464&partnerID=8YFLogxK

U2 - 10.1002/9780470753231

DO - 10.1002/9780470753231

M3 - Book

AN - SCOPUS:84889293464

SN - 1405127066

SN - 9781405127066

BT - Challenges in Colorectal Cancer

PB - Blackwell Publishing Ltd

ER -